NASDAQ
Baudax Bio, Inc. (BXRX) has a free cash flow growth of 29.98% as of Friday, May 29, 2026. This represents a 131.72% increase compared to its 12-month average of 12.94%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.